Pro-inflammatory cytokines such as TNF-α and IL-6 can promote estrogen metabolism into DNA-damaging metabolites and activate NF-κB signaling, which drives tumor proliferation [89,90]. The gene discussed is NFKB1; the disease is neoplasm.